HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma.

Abstract
Pulmonary veno-occlusive disease (PVOD), an uncommon cause of pulmonary hypertension (PH) has been reported following treatment of a variety of different malignancies with various chemotherapy. We report here the cases of two patients with non-small cell lung cancer (NSCLC) who developed fatal PH after combined treatment with surgery and a mitomycin containing perioperative chemotherapy (PCT). PVOD was documented at autopsy in one patient and was strongly suspected in the other patient who had an identical clinical presentation and in whom the work-up looking for another cause of PH was negative. Mitomycin was incriminated in both cases. Without questioning the potential interest of perioperative chemotherapy in resectable NSCLC, these observations illustrate the risks related to the combination of pneumotoxic chemotherapy and thoracic surgery.
AuthorsF Gagnadoux, F Capron, B Lebeau
JournalLung cancer (Amsterdam, Netherlands) (Lung Cancer) Vol. 36 Issue 2 Pg. 213-5 (May 2002) ISSN: 0169-5002 [Print] Ireland
PMID11955658 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Mitomycin
Topics
  • Antibiotics, Antineoplastic (adverse effects, therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (therapy)
  • Combined Modality Therapy
  • Echocardiography
  • Electrocardiography
  • Fatal Outcome
  • Humans
  • Hypertension, Pulmonary (chemically induced)
  • Lung Neoplasms (therapy)
  • Male
  • Middle Aged
  • Mitomycin (adverse effects, therapeutic use)
  • Pulmonary Veno-Occlusive Disease (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: